Aviana Molecular Technologies, LLC
Orlando, FL
- UEI
- NX3XNGMMWJX7
- CAGE
- 5PN93
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 7040 Lake Ellenor Dr, Orlando, FL 32809, USA
- Website
- avianamolecular.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $75,000 |
| FY2023 | $110,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Aviana Molecular Technologies, LLC is a point of care diagnostic company based in Orlando, FL that is developing a miniaturized biosensor capable of attaching to smartphones and other smart devices through wireless connections for diagnostic testing. The company has been registered in the System for Award Management (SAM) since 2009 as a for-profit, limited liability partnership.
Aviana Molecular Technologies has received multiple contract awards from agencies like the Department of the Navy Bureau of Medicine and Surgery and the Department of the Air Force Materiel Command Research Laboratory. These awards have funded projects such as testing with surface acoustic wave (SAW) technology ($225,000), providing reports on their digital biosensing platform advancements ($35,000), biomolecular coating work ($75,000), and research and development of a portable COVID-19 diagnostic system using radio frequency detection methods ($996,799 SBIR Phase II with a total small business set-aside). The company has delivered products like biosensing platforms and diagnostic testing services to support the medical needs of the military. While most contracts were firm-fixed-price purchase orders, Aviana also received a definitive SBIR Phase II contract. The periods of performance ranged from two weeks to three years, with work locations including their Orlando division as well as government facilities.
SBA capabilities narrative
point of care (POC) diagnostic company developing a miniaturized biosensor capable of attaching to a smartphone/smart device through Bluetooth or other wireless connections. The company's diagnostic system is a simple-to-use, potentially highly sensitive diagnostic platform that can accurately, within 10 -20 minutes, detect a target infectious disease, biomarkers or proteins in both clinical (human and animal) and scientific research settings.
Quick answers
Is Aviana Molecular Technologies, LLC registered in SAM.gov?
Yes. Aviana Molecular Technologies, LLC's SAM.gov registration is active through February 11, 2027.
What is Aviana Molecular Technologies, LLC's CAGE code?
Aviana Molecular Technologies, LLC's CAGE code is 5PN93, and its Unique Entity ID (UEI) is NX3XNGMMWJX7.
How much has Aviana Molecular Technologies, LLC received in federal contracts?
Federal contracts obligated $185,000 to Aviana Molecular Technologies, LLC in fiscal years 2023 through 2027.
What is Aviana Molecular Technologies, LLC's most recent federal award?
Aviana Molecular Technologies, LLC's most recent federal contract award is Aviana - testing with saw technology (N3239823P0705), from Bureau of Medicine and Surgery (Navy), on September 30, 2023.
On GovTribe
See Aviana Molecular Technologies, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors